Jul 7, 2020 04:49PM
Jun 2, 2020 07:42AM
Jun 2, 2020 07:30AM
May 6, 2020 04:05PM
May 1, 2020 08:35AM
Apr 3, 2020 03:00PM
Apr 1, 2020 09:03AM VIVUS (VVUS) Announces $11.55 Million Registered Direct Offering of Common Stock
Apr 1, 2020 09:02AM
Mar 31, 2020 07:45AM
Mar 31, 2020 07:30AM
Mar 3, 2020 04:05PM
Mar 2, 2020 07:34AM
Mar 2, 2020 07:30AM
Feb 19, 2020 07:30AM VIVUS Announces Commercial Launch of Qsymia® in the Republic of Korea Establishing New Royalty Revenue Stream
Feb 5, 2020 07:34AM
Feb 5, 2020 07:30AM
Feb 5, 2020 07:30AM
Jan 7, 2020 07:35AM
Jan 7, 2020 07:30AM
Dec 31, 2019 07:31AM
Dec 31, 2019 07:30AM VIVUS Adopts Stockholder Rights Plan
Dec 18, 2019 07:31AM
Dec 18, 2019 07:30AM
Nov 20, 2019 07:32AM
Nov 20, 2019 07:30AM
Nov 5, 2019 04:05PM
Oct 21, 2019 07:30AM
Aug 6, 2019 04:05PM VIVUS Reports Second Quarter 2019 Financial Results
Aug 5, 2019 07:35AM
Aug 5, 2019 07:30AM
Jun 26, 2019 04:05PM
May 30, 2019 09:30AM
May 29, 2019 05:41PM
May 29, 2019 04:44PM
May 28, 2019 07:35AM VIVUS (VVUS) Commences Phase Four Safety and Efficacy Study of Qsymia in Obese Adolescents
May 28, 2019 07:30AM
May 15, 2019 07:53AM
Apr 30, 2019 04:05PM
Feb 26, 2019 04:05PM
Feb 26, 2019 04:05PM
Jan 14, 2019 07:33AM
Jan 14, 2019 07:30AM Data Supporting the Cardiovascular Safety of VIVUS’ Qsymia® Published in The Journal of Clinical Endocrinology & Metabolism
Nov 1, 2018 04:10PM
Nov 1, 2018 04:10PM
Sep 21, 2018 07:30AM
Sep 21, 2018 07:30AM
Sep 10, 2018 07:31AM
Sep 10, 2018 07:30AM
Sep 10, 2018 07:30AM VIVUS Announces 1-for-10 Reverse Stock Split
Aug 27, 2018 07:32AM

322,245 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All